New Strategies Needed As China Shakes Up Drug Class Rules?

Like a stone being thrown into a pool of calm water, the China Food and Drug Administration released on March 9 "Document 51, Reform Plans for Chemical Drug Registration", stirring up immediate reactions from the pharma industry1.